{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.580","meta":{"versionId":"5","lastUpdated":"2019-03-19T01:00:22.000-04:00"},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\">\n      <h2>Trastuzumab administered within 12 months of diagnosis</h2>\n      <p>This value set includes codes from the following code systems:</p>\n      <ul>\n        <li>Include these codes as defined in \n          <code>http://www.nlm.nih.gov/research/umls/hcpcs</code>\n          <table class=\"none\">\n            <tr>\n              <td>\n                <b>Code</b>\n              </td>\n              <td>\n                <b>Display</b>\n              </td>\n            </tr>\n            <tr>\n              <td>G9835</td>\n              <td>Trastuzumab administered within 12 months of diagnosis</td>\n              <td/>\n            </tr>\n          </table>\n        </li>\n      </ul>\n    </div>"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.580","version":"20190319","name":"Trastuzumab administered within 12 months of diagnosis","status":"active","date":"2019-03-19T01:00:22-04:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","concept":[{"code":"G9835","display":"Trastuzumab administered within 12 months of diagnosis"}]}]}}